QC
ENFN

Quadrature Capital’s Enfusion, Inc. ENFN Stock Holding History

Quadrature Capital’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,059
Closed -$94.1K – 1472
2024
Q2 		$94.1K Sell
11,059
-767
-6% -$7.02K ﹤0.01% 1036
2024
Q1 		$109K Buy
+11,826
New +$104K ﹤0.01% 1121

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
NCM
Nellore Capital Management Redwood City, California $783M AUM 2.58% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Quadrature Capital's ENFN Position: Q3 2024 in Review

Quadrature Capital sold out of Enfusion, Inc. (ENFN) in Q3 2024, closing a stake of 11,059 shares — an estimated $94.1K sold.

Quadrature Capital first reported a position in ENFN in Q1 2024 and held it in 2 quarters. The position peaked at $109K in Q1 2024. 109 funds tracked by Wall St. Rank hold ENFN as of Q3 2024.

  • Quadrature Capital reported no remaining Enfusion, Inc. position as of Q3 2024 after selling out during the quarter.
  • Quadrature Capital sold 11,059 Enfusion, Inc. shares in Q3 2024, an estimated $94.1K.
  • Quadrature Capital first reported a position in Enfusion, Inc. in Q1 2024 and held it in 2 quarters.
  • Quadrature Capital's Enfusion, Inc. position peaked at $109K in Q1 2024.
  • 109 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q3 2024.

Based on Quadrature Capital's 13F filing for Q3 2024, filed 14 Nov 2024.